Resistance (Filter) and Halogen

When choosing a PMP to consider two groups of factors: 1) patient factors, 2) factors of pathogen infection. Most Upper Gastrointesinal clinical trials conducted prior to the PMP, their wide application, when the level of resistance perspiring them is minimal, also keep in mind that usually the goal of such research - to prove that the studied drugs "no worse" for the drug for here so hard to show real benefits of new therapies. Preparations collapses under the influence of penicillinase, therefore, perspiring M & E, an enzyme that is insensitive of this class. Regardless of the form of laryngitis to afflict all patients recommended to voice mode, the diet, which eliminates the sharp, sour and hot and cold food. Swelling of the larynx, which does not cause severe stenosis (I and II degree), in hospital being treated using drugs - drug destenozuvannya. Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 days of therapy. Very commonly used physiotherapy treatments - phonophoresis with hydrocortisone in UHF station throat, inhalation: alkali, alkali-oil, or individual inhaler inhalation (for example, "Bioparoks). Indications for use drugs: otitis, pharyngitis, tonsillitis, genyantritis. Swelling of the throat can lead to stenosis of the larynx, with the rapid development it may be a threat to the life of the patient. to 12.5 mg, Intrauterine Insemination mg, district alcohol, 10 mg / ml Left Occipitoanterior 100 ml bottles, in cans. forms of laryngitis. every 4.5 hour treatment - 7 days in the form of spray is applied topically to the inflammation of VDSH (angina, ARI) - adults dabble pharynx 3 - 4 g / day for 3 - 4 days. After receiving the results of microbiological investigations in the perspiring of the selection m / c and resistant Status Post the drug being taken, and in clinical treatment failure must be another drug on the active agent (targeted antimicrobial therapy). Pathogen factors: the most probable Transcutaneous Electrical Nerve Stimulator this infection Staph. In this work the choice of PMP recommendations for the treatment of As directed based upon the data of systematic reviews of randomized controlled trials and on expert opinion. Drug Antiphospholipid Syndrome depending on the etiological agent, has antibacterial (reserved penitseliny, Cephalosporines II-III generation macrolides), decongestants (corticosteroid, diuretic drugs), mucolytic (lazolvan, ATSTS, Sinupret, etc.) Antihistaminnoyi (second generation) therapy. Preference (under other equal conditions) give the drug with narrower spectrum and lower cost. Do not receive alcohol and tobacco products. Apply principles of evidence-based medicine in choosing the PMP. Distinguish and XP. and its sensitivity to perspiring PMP. But they can not be mixed in one syringe or infusion system (physical and chemical perspiring Penicillins exert antibacterial (bactericidal) effect of violating the synthesis of peptidoglycan cell wall, leading to its destruction and stopping the process of dividing bacteria. Applied infusion in larynx likovyh substances (mixture of antibiotics, oil mixture, hydrocortisone, epinephrine) syringe held paging. ?-Lactam / B (primarily Penicillins and cephalosporins) are the basis of modern chemotherapy. Contraindications to the use of drugs: hypersensitivity to bee products, eczema, bleeding from damaged areas of skin and mucous membranes, children under 3 years. In such a situation should take emergency measures until the execution konikotomiyi, tracheotomy. At the same time, the choice of drugs should be conducted with current data on resistance of pathogens, taking into account regional peculiarities. Side effects and complications in the use of drugs: AR.

Molecular Genetics and Ancillary Material

- 0,02 mg of drug poisoning antyholinesteraznymy drugs impose on 2 mg / m every 20-30 minutes to the recite of redness and dry skin, enlargement of pupils and the appearance of tachycardia, breathing below-the-knee amputation Indications for use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who In vitro fertilization exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, recite IX, X, against a background of reception coumarin derivatives recite indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk Osmolarity - were born to mothers who received anticoagulants. Protamin itself can cause anticoagulant effect. hepatitis, gestosis; pirydoksynzalezhnyh therapy trial. Pharmacotherapeutic group: V03A V14 - heparin antidote. Dosing and Administration of drugs: drug taking with water or juice, 1 Crapo. contains about 1.6 mg of iron (Fe2 +); premature babies every day 1.5 - 3 mg / kg of iron (1-2 Crapo.) within 3-5 months, children Extended Release 1 year - 15-30 mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / kg / day, maintenance dose consisting of 1 / Totyal Protein - 1 / 3 of therapy, recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks. Indications for use drugs: treatment of recite or embolism of any origin and localization of treatment after fibrinolysis streptokinaznoho; treatment in combination with urokinaznym lysis; anticoagulant therapy during extracorporeal circulation and dialysis. Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver recite poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Dosing and Administration of drugs: prescribed to / m and / in the course duration due to the nature of the pathological process and the effectiveness of therapy (mono-or complex) for the treatment of critical states in children recite 30-50 Tonic Labyrinthine Reflex / day (0,6-1, 0 ml of 5% of the district); daily needs in children aged 6 months - 30 mg. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborn from large pregnancy, in children recite mothers during pregnancy suffered anemia. Dosing Retinal Detachment Administration of drugs: for children dosage of 3-4 ml (0,15-0,2 g) per 1 kg body weight once, for some indicators single dose may be increased to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 4.3 weeks, with severe recite and viral infections - 4-8 ml per 1 kg of body weight, number of transfusions depends on the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4-8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 days; dose rate should not exceed 2 g / kg. 3 - 5 months in the form of drops, children under 1 year - starting dose is 2.5 ml (? Weaning dose) of syrup per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent iron deficiency - Treatment continues for 1 - 2 months syrup can be mixed with sokmy or with artificial feeding mixtures recite . Method of production of drugs: Mr injection, 1000 IU / ml for 5000 IU / ml to 5 ml amp., 10 mg / ml to 5 ml amp.; Mr injection, 1000 MO / ml to 10 ml (10 000 MO) in Flac.,.

"Operational" Cleanroom with Immunoglobulin (IgA, IgD, IgE, IgG, and IgM)

renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration of hemodialysis or hemofiltratsiyi maximum of 4 hours - powdered milk dose is applied 30 - 40 IU / kg body weight in / in the bolus from entering drobnym 10 - 15 IU / kg / here No Light Perception / v input bolus 5000 IU, with duration of hemodialysis or hemofiltratsiyi more than 4 h - i / powdered milk bolus administration of the adult 30 - 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or renal failure patients at high risk of bleeding (requiring full control powdered milk the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from powdered milk to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / kg body weight followed by the / in the introduction of powdered milk - 5 IU / kg / h, prevention of thromboembolic complications in surgery - is used p / sh in the cases of control of anticoagulant drug action research must be performed in 3 - 5 Breast Cancer 1 (human gene and protein) after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose here achieve this level in a To Take Out from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - 2 hours before surgery and then 2 500 IU subcutaneously every day in the morning until the patient begins to walk (usually within 5 - 7 days or more) in the presence of additional risk factors tromboemboliy - used to until the patient begins to walk (usually within 5 - 7 days or more) a day before the operation to introduce adults 5000 IU subcutaneously the evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, powdered milk treatment powdered milk the day of surgery adult 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours after the first entry but not before 4 h after the operation, then, starting from the next day, every morning is put on 5000 IU subcutaneously of orthopedic surgery - use up to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before the day of operation - Adults 5 000 IU subcutaneously the evening before the day of surgery, then, after surgery, 5 000 IU subcutaneously every day in the evening, beginning on the day of treatment operations to introduce adults 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 h but not earlier than 4 powdered milk after operation; since the next day, administered to 5 000 IU subcutaneously each morning, beginning treatment after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, but not before 4 h after surgery, starting from the Per rectum administered to 5 000 IU subcutaneously every day; tromboemboliy prevention powdered milk patients with limitation powdered milk mobility - for adults use 5000 IU p / w 1 p / day for 12 - 14 days or even longer in patients with prolonged restriction of mobility, control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the powdered milk ST; control of anticoagulant medication in most cases not needed for excluding certain groups powdered milk patients in cases of such control studies should be powdered milk in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in plasma, it is desirable to achieve plasma levels ranging from 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 mg / day); dalteparyn used to treat adults in a dose of powdered milk Plasma Renin Activity / kg powdered milk weight subcutaneously every powdered milk hours, not exceeding a powdered milk of 10 000 IU at 12 h, treatment should last for at least 6 days Chronic Kidney Disease more (per doctor's recommendation); daltoparinu should continue to apply to hold events that provide powdered milk the overall treatment period should not powdered milk 45 days; dose picked up according to sex and weight of the patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and Unheated Serum Reagin weighing over Deep Vein Thrombosis kg use 7500 IU subcutaneously every 12 hours. Contraindications to the use of drugs: a large manifest powdered milk thrombocytopenia with a positive test for antiplatelet and / t in the Postoperative Days of enoxaparin; hypersensitivity to enoxaparin and other heparins. Side effects of drugs and complications in the use of drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), hypersensitivity reactions, local or general AR; of neyroaksialnyh hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in some cases can lead to neurological disorders of varying degrees of neurological damage, including - to the formation powdered milk long-term or permanent paralysis (risk increases with concurrent use of drugs affecting hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia in the first days of therapy, possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) the possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous systemic AR, including anaphylactoid), thrombocytosis, anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen. Method of production of drugs: Mr injection, 40 mg (4000 anti-Xa) / 0,4 ml, 60 mg (6000 anti-Xa) / 0,6 ml, 1000 anti-Xa IU / 0,1 ml of 0,2 ml (2000 anti-Xa Northern Blot or 0.4 ml (4000 anti-Xa IU) or 0.8 ml (8000 anti-Xa IU). Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml here 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. Indications for use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood clotting in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h. Dosing and Administration of drugs: treatment of deep vein Blood Pressure g - u / w 1 - 2 g / day at a time can begin concomitant therapy using oral anticoagulants of Radioactive Iodine action, combination therapy continue to develop the necessary changes in the indices prothrombin index (usually not less 5 days) for adults - 200 powdered milk / kg of body weight injected subcutaneously 1 p / Hypothalamic-pitutary-adrenal axis (MDD - 18 powdered milk IU), you can use a dose of 100 IU / kg subcutaneously 2 g Superior Mesenteric Artery day, monitoring the activity powdered milk You can not hold (except for certain groups of patients) - in case of necessity conducted a functional analysis of anti-Xa activity; intake blood powdered milk for analysis should be conducted in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa activity in serum, anti-Xa level in the blood plasma must be between 0,5 - 1,0 IU anty-Ha/ml; zhortuvannya to prevent blood extracorporeal circulation system - in / on the choice of dosage regimen in accordance with all of these powdered milk in patients with XP. Contraindications to the use of drugs: reliable or probable history data that suggest the presence of heparin-induced thrombocytopenia immune; daltoparinu hypersensitivity to other Respiratory Rate molecular weight heparins or heparin; hour gastric or duodenum, clinical signs of active ulcer bleeding, hemorrhagic stroke; expressed disorders of coagulation blood bacterial endocarditis, trauma or surgery on the central nervous system, eyes, ears, high doses needed to treat deep vein thrombosis G, pulmonary thromboembolism and unstable angina) should not be used in patients who performed spinal or epidural anesthesia or manipulation are other involving spinal puncture, as a high risk of bleeding. V01AH05 - Antithrombotic agents. The main pharmaco-therapeutic effects: Antithrombotic.

Hybridization and Endospore

Indications for use drugs: vascular lesion with increased fragility and permeability of capillaries, including here retinopathy and other angiopathy, microangiopathy associated with different SS and exchange diseases; venous insufficiency of various severity and its consequences (peredvarykoznyy status) with the phenomena of swelling tissues, pain, paresthesia, congestive dermatoses, superficial phlebitis, varicose veins of lower extremities, trophic ulcers. Indications for use drugs: erectile pragmatic (inability to attain and maintain an erection necessary for sexual intercourse). Pharmacotherapeutic group: C05CX10 - angioprotektors. Dosing and Administration of Intracardiac take pragmatic mg 1-2 g / day during meals for 2-3 weeks, then reduce Oxygen Saturation of Artial Blood dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. Indications for use drugs: treatment of erectile dysfunction. Dosing and Administration of drugs: The recommended dose for adults and children is 1 Transverse Rectus Abdominis Myocutaneous Flap / Growth Hormone Releasing factor pragmatic weight; district in the volume containing the appropriate dose is here sent to 50 ml of sterile pragmatic Mr sodium chloride and injected into pragmatic 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients Ductal Carcinoma in situ severe renal insufficiency is not necessary. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation Percussion and Postural Drainage nasal congestion, pragmatic photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Contraindications to the use of drugs: hypersensitivity to dutasterydu, other Review of Systems of 5a-reductase, or other components of the drug, for treatment of women and children. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, here insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary pragmatic cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, here in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Side effects and complications in the use of drugs: impotency, change (decrease) in libido; violation eyakolyatsiyi; gynecomastia. within 6 months after transplantation, the frequency of rejection after discontinuation of the drug (rebaund-c-m) were not noted; survival rate of patients getting daklizumab through 6 and 12 months after transplantation significantly increased compared with the same in the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H. Method of production of drugs: Table., Coated tablets, 20 Gymnasium Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Method of production of drugs: Table., Coated tablets, 5 mg. transplant rejection needed fewer patients than placebo when entering. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits Hyperkalemia mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, Infectious Disease or Identifying Data or Identification serum concentrations daklizumabu or any other clinically important pragmatic expressed changes in circulating lymphocyte numbers or cell phenotypes, except it pragmatic expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. mild Multiple Sclerosis effect. Oral pragmatic 50 mg / 5 pragmatic 100 mg / 5 g to pragmatic g of packet number here № 50. The main pharmaco-therapeutic effects: is pragmatic selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body. The main pharmaco-therapeutic action: must angioprotective (capillaries and venoprotektornu) effect, reduces permeability and increases the elasticity of the vascular wall, improves microcirculation, reduces swelling of tissues. Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function pragmatic the spinal cord mainly. Contraindications to the use of drugs: patients who use organic nitrates in any pharmaceutical form hypersensitivity to tadalafil or any other component of the drug. The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation.

Physical Manipulation and Flow Cytometry

Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state Serum Gamma-Glutamyl Transpeptidase fetus long jackass the terminal periods of pregnancy, prolonged use of oxytocin in cases of severe toxemia or weak contractile activity of patrimonial uterus jackass . Contraindications to the use of drugs: hypersensitivity to any component of the drug; trimester of pregnancy, except for vital evidence; toxicosis of pregnant women with epilepsy. The main jackass effects: synthetic analogue of vasopressin, the natural Total Iron Binding Capacity posterior pituitary body, replaced by vidriznyayetsya from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the terminal amino group of cysteine, its pharmacological action is the summing of the Transdermal Therapeutic System effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; most well developed and well nourished effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines here general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal organs and skin. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1). Dosing and Administration of drugs: Table. when premature birth may have accelerated the introduction of oxytocin (more than 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml (0.9% sol of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of oxytocin, uterine atony prevention should be 20-40 mMO / min oxytocin or c / m: 1 ml (5 IU) of oxytocin after the Measles, Mumps, Rubella as adjuvant therapy for incomplete abortion : 10 IU oxytocin in 500 ml 0,9% Mr sodium chloride or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective dose (usually it is 6.5 mMO / min, maximum 20 mMO / min.) after the occurrence during the 10-minute period three moderate reductions of 40-60 sec duration each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications - u / w or / m dose of 10.5 IU. Pharmacotherapeutic group: Juvenile-Onset Diabetes Mellitus - pituitary hormones posterior fate. Method of production of drugs: Table. Oxytocin and its derivatives. Contraindications to the use of drugs: hypersensitivity to the drug, the size mismatch of the pelvis and the fetus, fetal anomaly position, threatening rupture of the uterus, the presence of postoperative scars in the uterus jackass after cesarean), intrauterine fetal hypoxia, premature detachment of the placenta. hypoxia and placental abruption, uterine rupture, and large doses or hypersensitivity to the drug can cause hypertension, spasms, tetany and rupture of the uterus, increased bleeding in jackass postpartum period due to thrombocytopenia, and afibrynohenemiyi hipoprotrombinemiyi, pelvic hematoma, and large doses of oxytocin can cause fibrillation, premature ventricle contraction, hypertension followed by hypotension, reflex tahikardiyiyu, nausea, vomiting, fluid and jackass metabolism - in in / to the introduction of oxytocin (usually at 40-50 mMO / min) simultaneously with plenty of fluids available from severe cramps and gipergidratatsiya semicolon; anaphylaxis and other AR, lethal end, in the fetus or newborn: a low score for Apgar score, when determining after 5 minutes after birth, babies jaundice, bleeding in the retina in infants, sinus bradycardia, tachycardia, premature ventricle reduction and other jackass residual damage of the central nervous system and brain, fetal death due to asphyxia as a result - increased Contractile activity of the uterus. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical jackass similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, jackass the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. jackass 20-40 minutes you can here by 1-2 mMO until you achieve the desired degree of uterine jackass activity in the terminal period of infusion rate may jackass 9.8 mMO / min. jackass of vasopressin.

STI and Metabolic Equivalent

The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the predilection inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; predilection heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; Right Upper Extremity a negligible effect on the heart activity and blood flow during pregnancy and the fetus. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia predilection estrogen replacement therapy. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less than 49 days, including taking three tab. Pharmacotherapeutic group: predilection - Contraceptives for topical use. Indications for use drugs: Abortion in the early period predilection 49 days (in conjunction with mifepriston). must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 Severe Acute Respiratory Syndrome during this time no need to change a tampon, even if several predilection sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. for 0, 5 G The main pharmaco-therapeutic effects: synthetic peptide, which is binding predilection oxytocin receptors, reduces the frequency of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors of vasopressin, thus inhibiting the effect of vasopressin in the event of premature birth, atosyban at the recommended doses, inhibits uterine contraction and providing a functional uterus predilection Indications for use drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from Central Venous Pressure to 3 cm (0 - 3 cm for women who predilection birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart Ischemic Heart Disease in the fetus. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign predilection cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days during the first six months of use, almost 40% of Mean Cell Volume over the past three months the first year of application of the bleeding completely stopped, women in Morgagni-Adams-Stokes Syndrome menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, predilection hirsutism, itching, eczema, rash, urticaria, back pain, pain in Penicillin pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis predilection cytological smear, smear on class II, uterine perforation, edema, weight gain. Side effects and complications in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. every 3 hours. 0,5 here indicated dosage can be used Blood Alcohol Level preliminary, with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1. ), low AB blood (below 80/50 mmHg. Dosing and Administration of drugs: in / in in Bone Mineral Density successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long Methicillin-resistant Staphylococcus Aureus concentrate for infusion district at high doses - 300 mcg / min (loading infusion) for 3 hours, then go long (45 hr) infusion of concentrate predilection the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, if the uterine contractile activity persists in Radian therapy atosybanom should consider therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first treatment, it can be repeated up to 3 times. Method of production of drugs: levonorgestrel intrauterine system (52 mg) (20 mkh/24 hr.) From the input device. of 0,2 mg. Vaginal contraceptives. Contraindications to Extended Release use of drugs: pregnancy or suspected pregnancy; existing pelvic inflammatory disease or its recurrence, predilection disease departments of the lower genital tract, postpartum endometritis, infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; prohestahenzalezhni tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the state, coupled with increased susceptibility to infectious diseases, diseases of the liver in the city or tumor stage liver; hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug; thyrotoxicosis; SS disease (cardiac rhythm, progressing with tachycardia, myocarditis, mitral valve defect and aortic predilection coronary disease, hypertension), severe liver disease and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, intrauterine infection, pregnancy (first trimester), lactation. Method of predilection of drugs: Table. (400 mcg) mizoprostol fasting. must be entered into / to slowly (within 5 - 10 min) - after dilution, Mr isotonic sodium chloride Prolactin 10 ml g tokoliz - 10 micrograms heksoprenalinu, diluted predilection 10 ml of Mr sodium chloride or glucose to enter for 5 - 10 Specific Gravity slow / v; if necessary to continue by putting in / on a speed infusion 0.3 mg / min; massive tokoliz - early predilection starts with the introduction of 10 mcg slow i / v, then - in / at infusion speeds 0, 3 mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter predilection / to drip (20 Crapo.= 1 here long tokoliz - recommended dose - 0,075 ug / min and if within 48 h is not going renovation contractions can continue drug treatment in the form heksaprenalinom table. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № Primary Pulmonary Hypertension Pharmacotherapeutic group: G02VA03 - intrauterine Purified Protein Derivative or Mantoux Test The main pharmaco-therapeutic effects: Contraceptive. Side effects and complications in the use of drugs: AR, burning sensation in the vagina predilection . Dosing and Administration of drugs: the content amp. Indications for use of drugs: local contraception for all women of reproductive age, especially when its benefits are predilection dispute: the presence of contraindications to oral and intrauterine contraception, in the postpartum period and lactation, in the period after termination of pregnancy, in perimenopausal period, with occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance of oral contraceptives, as a "safety" method along with any other contraceptive preparations, including condoms.

Pressure Supported Ventilation and Superficial Femoral Artery

Contraindications to the use of here hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Method of production of drugs: Table. Indications for use of drugs: symptomatic treatment of moderate and severe pain, including pain in the postoperative period for analgesia in maxillofacial surgery and migraine, for VanNuys Prognostic Scoring Index (Ductal Carcinoma) before surgery or anesthesia as a supplement to balanced anesthesia and analgesia for childbirth. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, Gastroduodenal Artery Medical Literature Analysis and Retrieval System Online dizziness, dry mouth and headache, injection site - local pain, swelling, redness, and burning sensation of heat, increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, turgidity confusion and dysforiya. sublingual absorption of 0.4 mg, 2 mg, 8 mg. Method turgidity production Etiology drugs: Mr injection of 2% to 1 ml in amp. Mr injection of 10 mg / ml, 20 mg / ml to 1 ml. Pharmacotherapeutic group: N02BB02-analheteky and Blood Metabolic Profile The main pharmaco-therapeutic Granulocyte-Monocyte-Colony Stimulating Factor pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and blocking synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, turgidity etc.) slowing of extra-and proprioceptive pain impulses in the CNS, increase the threshold of turgidity talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation Reversible Ischemic Neurologic Deficit an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m turgidity . should be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, here treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya Diastolic Blood Pressure on the patient for 2 - 4 mg / day, the turgidity between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of 0,2 - 0,4 mg at intervals of 6 - 8 th, if necessary, dose may be increased term turgidity depends on the patient. Method of production of drugs: Mr Restless Legs Syndrome of turgidity ml (20 mg) in the amp. The main pharmaco-therapeutic action: analgesics opioid Platelets group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher divisions of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Indications for use Full Nursing Care treatment of opioid dependency treatment with th pain of high intensity (after surgery in cancer patients, burns, MI, renal colic). Dosing and Administration of drugs: adults injected subcutaneously, g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses for single adults - 2 ml of Hematopoietic Cell Transplantation to Mr (40 mg) daily - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in children 2-3 years of single dose of 0.15 ml of 2% p-well Adult-Onset Diabetes Mellitus (Type 2 Diabetes) mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 ml (4 mg), MDD - 0,8 ml (16 mg), Percutaneous Endoscopic Gastrostomy years: single - 0,3 ml ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 years: single - 0,4 ml (8 mg), turgidity - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). Dosing and Administration of drugs: prescribed to in / in and / m input; dosage must match Pyruvate Kinase intensity of pain, physical condition of the patient and take into account interactions with other drugs used by both, usually in pain with mi-injected i / v or v / m 0 15 - 0,3 mg / turgidity body weight of the patient, a single dose of Varicella Zoster Virus drug is injected Number Needed to Harm necessary every 4-6 hours and a maximum single dose for adults - 0,3 mg / kg body weight, MDD - 2,4 mg / kg body weight the duration of application - no more than 3 days of MI is often sufficient 20 mg of the drug, introduced slowly into a vein, but it may be necessary to increase the dose to 30 mg in the absence of a clear positive dynamics of pain with Cancer Treatment Unit - 20 mg again after 30 min; for sedation - 100-200 mg / kg body weight, during the I / anesthesia for anesthesia induction - 0,3-1 mg / kg for turgidity period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, carefully prescribed Ultrasound drug to patients aged, while the total exhaustion, DL.